Schedule 13G ownership disclosure

Vir Biotechnology Inc

Common Stock, $0.0001 par value · CUSIP: 92764N102

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • SB Investment Advisers (UK) Limited

    Shares: 13,116,977.00 · Class: 9.4%

  • SoftBank Vision Fund (AIV M1) L.P.

    Shares: 13,116,977.00 · Class: 9.4%

  • SVF Endurance (Cayman) Limited

    Shares: 13,116,977.00 · Class: 9.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-26-007174
Form type
SCHEDULE 13G/A
Filer
SB INVESTMENT ADVISERS
CIK
CIK 1731509
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub